Catalyst Funds Management Pty »

Taysha Gene Therapies shares owned by Catalyst Funds Management Pty

Quarter-by-quarter ownership of Taysha Gene Therapies (TSHA) shares owned by Catalyst Funds Management Pty from 13F filings

Historical chart of Catalyst Funds Management Pty investment in Taysha Gene Therapies

Tip: Access up to 7 years of quarterly data

All positions including Taysha Gene Therapies held by Catalyst Funds Management Pty consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Taysha Gene Therapies by Catalyst Funds Management Pty

Quarter filed Position value Share count Share price at filing
2026-03-31 $68k 15k 4.47
2025-03-31 $17k 12k 1.39

More positions owned by Catalyst Funds Management Pty

Apple Ordinary Shares (AAPL)
Rio Tinto Adr (RIO)
Arm Holdings Adr (ARM)
Astrazeneca Ordinary Shares (AZN)
Medline Ordinary Shares (MDLN)
Cisco Systems Ordinary Shares (CSCO)
Abbvie Ordinary Shares (ABBV)
Teradyne Ordinary Shares (TER)
TechnipFMC Ordinary Shares (FTI)
Elbit Systems Ordinary Shares (ESLT)
Exxon Mobil Corp. Ordinary Shares (XOM)
Walmart Ordinary Shares (WMT)
Cheniere Energy Ordinary Shares (LNG)
Revolution Medicines Ordinary Shares (RVMD)
Valero Energy Corp. Ordinary Shares (VLO)

View all positions for Catalyst Funds Management Pty

Top funds holding Taysha Gene Therapies

RA Capital Management
Goldman Sachs Group
venBio Select Advisor
BlackRock
Vestal Point Capital
Morgan Stanley
Rtw Investments
FMR
Vanguard Group
State Street Corporation
Vanguard Capital Management
Siren
Octagon Capital Advisors
Polar Capital Holdings
Barclays

View all funds holding Taysha Gene Therapies